Abstract: The present invention relates to a reliable method of prediction of lower respiratory tract infection or inflammation in humans, wherein the level of pancreatic stone protein/regenerating protein (PSP/reg) is determined in serum, and a high level is indicative of the development and the severity of the disease, allowing the classification of patients according to risk.
Type:
Application
Filed:
March 5, 2018
Publication date:
September 13, 2018
Applicants:
UNIVERSITY HOSPITAL OF BASEL, STEPSTONE DIAGNOSTICS SARL